Search Login Register

Off-Label Use Summary

Description: The practice of prescribing or using a drug outside the scope of the drug's official approved label as designated by a regulatory agency concerning the treatment of a particular disease or condition.

Also Known As: Off-Label Prescribing; Unlabeled Indication; Indication, Unlabeled; Indications, Unlabeled; Off Label Prescribing Show All >>

Networked: 609 relevant articles (30 outcomes, 81 trials/studies) for this Therapy

Key Diseases for which Off-Label Use is Relevant

  1. Hemorrhage : 3 outcomes 5 studies in 46 results
  2. Pain (Aches) : 3 outcomes 2 studies in 26 results
  3. Neoplasms (Cancer) : 2 outcomes 7 studies in 40 results
  4. Psoriasis (Pustulosis Palmaris et Plantaris) : 2 outcomes 1 study in 11 results
  5. Neuralgia (Stump Neuralgia) : 2 outcomes 1 study in 6 results
Show All >>

Drugs Related to Off-Label Use

  1. recombinant FVIIa (rFVIIa)
  2. gabapentin (Neurontin)
  3. Factor VIIa (Activated Factor VII)
  4. Ribavirin (Virazole)
  5. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
  6. Vaccines
  7. rituximab (Mabthera)
  8. bevacizumab
  9. pimecrolimus (Elidel)
  10. TNFR-Fc fusion protein (etanercept)
Show All >>

Therapies Related to Off-Label Use

  1. Individualized Medicine
  2. Liver Transplantation
  3. Biological Therapy
  4. Optical Devices
  5. Intensive Care (Surgical Intensive Care)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.